Wessex Cancer Support Annual Report and Accounts 2024 .LI. -ILI EX:TJ ••lb essex (ancer Support Registered Charity Number 01110216 Registered Company Number 05416311 IA company limited by guaranteel Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 Contents page Legal and administrative information Year in review Report of the Trustees Independent auditor's report 20 Consolidated statement of financial activities 24 Consolidated and Charity balance sheets 26 Consolidated statement of cash flows 27 Notes to the financial statements 28 Wesse¥ can￿r Support R￿15t￿yed Cornpany No. 05416311 Page 2 of 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and account5 for the year ended 31 December 2024 Legal and administrative information Charity Name Wessex Cancer Support Company Number 05416311 Charity Registered Number 01110216 Registered Office 91-95 Winchester Road Chandler's Ford Eastleigh, S053 2GG The directors of the charitable company are its trustees for the purw5es of charity law. The trust￿5 and offi￿rS serving during the year and Sin￿ the year end were as follows: Board of trustees Mrs D Cutler Mr M Miles FCA Mr J Plumtree FCA Mrs R C Brockwell Mr J Clough Mrs E Galambos Mr T Jones FCA Ms L Kinsella Mrs T Laalami-Asgari Ms G McKnight Chair Treasurer Vice Chair Appointed 19 De￿mber 2024 Appointed 25 September 2024 Appointed 2 January 2024 Dr E Arden-close Resigned 15 May 2024 Secretary Mr D Robertson CA(SA) Chief Executive Rachel Billsberry-Grass Legal Advisors Paris Smith LLP London Road Southampton, S015 2AE Auditors Azets Audit Services Athenia House, 10-14 Andover Road Winchester Hampshire, S023 7BS Investment Advisors Sarasin & Partners Juxon House, 100 St Paul's Churchyard London EC4M 8BU Wessex Call￿[ Support Registw'ed C(Mnpany No. 05416311 Page 3 of 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 Bankers The Royal Bank of Scotland 56 High Street Southampton, S014 2NP Co-operative Bank PO Box 250, Delf House Skelmersdale, WN8 6 Wessex (3n￿r SuptK>rt Regisiered Cw)pany No. 054 16311 Page 4 0142 We55ex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 Year in Review A joint message from our Chair and Chief Executive We are delighted to share our Annual Report and Review for 2024, the final year of our Can￿r Support for A//strategy. In the past year we have supported 1,811 people, comfortably exceeding our aim to double our client numbers from our 2021 benchmark of 788. The number of supp)rt interactions has increased to 19,001 (2023: 16,560) and we have maintained a high quality of servi￿, with 99 % of clients rating the Servi￿5 they received as being gc(rfJ or excellent. This would not have been possible without the dedication of all our donors, volunteers and staff, to whom we extend our sin￿re thanks. Our serVI￿S focus on the emotional health and wellbeing of anyone affetted by cancer, whether it is the person living with can￿r themselves, or their loved ones. The majority of our clients have been supported through one of our four can￿r support centres. At the centres, clients can access personalised holistic support which might include befriending, counselling and complementary therapies as well as gentle exercise classes. During the past three years we have been focused on enhancing accessibility and inclusivity across our seNices. This included the launch of a digital Servi￿ in 2023; in the past year we have delivered 1,362 support interactions online, up over a third year on year. We are clear on the Importan￿ of collaborations and in the past year we have worked closely with other organisations, both large and small, across the region. These include the Wessex Cancer Allian￿ and the region's main cancer hospitsls, charities such as Beyond Reflections, Help and Care, Macmillan and Maggie's and small local healthcare providers and support groups. These relationships are testament to the value of our servI￿s, and help to inform our Servi￿ development, ensuring what we deliver remains relevant for Iccal needs. We are proud of these achievements, but must recognise that 2024 has been another year that has tested our resilience as an organisation. We have seen continued challenges in our fundraising with a landscape that remains highly competitive. In common with many charities in the sector, we have had difficulty in recruiting and retaining tslented fundraisers. These factors, coupled with the added pressure of increased costs, had a negative impact on our income in 2024. Unfortunately, these challenges have a150 coincided with a year where legacy income has been much lower than average. Fortunately our designated reserves pot, which was established for this eventuality, has helped to cover the resulting loss. Legacies is a highly unpredittable income stream, and our results in 2024 when compared to re￿nt years, highlights the value and necessity of these designated reserves. Despite the generally tough fundraising climate, there have been some highlights during the year, including a suc￿Ssful Swim for Hope across the Solent, a partnership with Harbour Hospitals, and the launch and sell out of a new Christmas Carol concert on the Isle of Wight. In retail the picture has been very positive as we have sought to maximise the opportunities presented by a nation that has been more keen to save both money and the planet. We were excited to open a new shop in Westbourne, our first in Dorset, and have been pleased by the solid results it has achieved in the first year. Across all shops we have fccused on quality of stock, our people, priang and promotions and enjoyed our best year of sales ever, with a substsntial increase in the contribution to the charity. With a very healthy reserves position, we have also benefitted from a strong return on investments, with our net gains helping to mitigate some of our losses. Wessex tsn￿r Sijpport Regi￿ered Company No. 05416311 Page 5 of 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 A big focus for 2024 has b*n developing a new five-year strategy which will take us through to the end of the decade. Our commitment to providing personalised emotional and wellbeing support will not change, but we continue to explore how best to structure our serVI￿S to reach more people with the funds we have available. During 2025 and beyond, we will carefully introduce new servi￿5 such as talks, courses and more support groups, which we expert will gradually redu￿ the pressure on our more expensive one to one services. We are expecting continued challenges in 2025, not least the impact of the changes to National Insuran which will add approximately £40,000 to our core costs. Our five-year strategy is mindful of this and highlights the three interconnected pillars on which the successful delivery and growth of our services will depend; namely Marketing, Income Generation and People. To this end we are delighted to welcome a new Director of Fundraising and a new Head of Marketing in early 2025, and we will continue the development work started in 2023 to improve our HR practices. Our core income must grow substantially to meet the future cost of delivering our serVI￿S for a rising number of clients. It will take time to build sustainable income but our robust financial management and generous legacy donations over the past few years, have positioned us with strong reserves to support this period of growth. The ServI￿S provided by Wessex Can￿r Support are vital. With a NHS which is under huge strain, healthcare service that is likely to be rn0￿ impersonal in future, our serVI￿S will be needed for a long time in the future. There are still thousands of people in the region who simply do not get the support they need to cope with the impact of Can￿r. They might experience feelings of isolation, sadness and depression, or being overwhelmed, feelings that can impact on all areas of their lives. We aim to be the￿ for them. With your help, we can continue to make a meaningful difference for people with cancer and their loved ones. Thank you to all the people we￿e worked with over the past year - the generous supporters, trustees and volunteers; the organisations we've partnered with in Servi￿ and fundraising; and our dedicated and hard- working colleagues. We are also enormously grateful to all the clients who have trusted us when they are at their most vulnerable. Wami regards, Diane Cutler, Chair of Trustees and Rac illsberry-Grass, CEO Wessex Cancer Supwrl Registered C￿1panY No. 05416R I I Page 6 of 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 Report of the trustees The trustees present their report and the audited financial ststements for the twelve months ended 31 De￿mber 2024. The financial statements have b￿n prepared in accordance with accounting p)licies set out in the notes to the accounts and comply with the charity's memorandum and articles of assc(iation, last amended on 19 July 2023, applicable law and the requirements of the Ststement of Recommended Practice Accounting and Reporting by Charities, Charities SORP (FRS102). Vision and Mission Vision Everyone in Wessex affected by can￿r will have access to personalised support so that they can fa￿ what's ahead with more confidence. Mission Our mission is to engage with local communities to help improve the emotional health and wellteing of anyone affected by Can￿r. Our work and impact in 2024 Wessex Can￿r Support ServI￿S are open to people at any stsge and with any type of cancer, and their loved ones, to help improve their emotional health and wellbeing. Children and young people make up a very small proportion of the people we support and during 2024 the Trustees decided to focus on our servi￿5 on the adults aged 18+ years. We aim to offer a supportive community and personalised services that clients can access as they need, servI￿s include counselling, complementary therapies, befriending, movement and exercise sessions and therapeutic choirs; these are delivered both individually and in group setting5. Our thr￿ year strategy Can￿r Support for All concluded at the end of 2024. This section outlines our achievements against the four strategic priorities outlined in the strategyi and summarises our priorities and plans for the next stage in the organisation's development. Strategic priority I: More people will access our services During 2024 we supported 1,811 clients, and delivered a record number of support interattions at 19,001. This total comfortably exceeded our target to be reaching an average of 1,576 clients per annum during the life of the strategy (2023.. 1,836; 2022: 1,206). Cancer support centres The majority of clients accessed support in one of our cancer support centres. Numbers stayed steady compared to last year, despite our marketing resour￿ being stretched very thinly. This is testament to the strong reputation we have built in the region and in the local areas of each of our ￿ntres. We have continued to offer core services across all centres, while remaining agile on a Ic(al level to evolve to meet the needs of the local community. In 2024, we continued to rLJn groups outside of our normal operating hours to accommodate different needs. Wessex tsn￿r Support R￿Istered Corni)any No. 05416311 Page 7 0142 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 We also made permanent our 2023 trial to open our Bournemouth Centre 5 days per week (previously 4). This has helped to ease pressure on capacity. During the prO￿sS of strategy planning, we acknowledged how challenging it has been to manage waiting lists when offering an open-ended service. During 2024 we planned how to address this and from early 2025, have introduced limits on our one-to-one services, encouraging clients to engage in other servi￿5 such as drop-in tefriending or group support sessions. Early results suggest this has had a positive impact, reducing waiting lists across all ￿ntres. Towards the end of 2024, we were thrilled to finally identify a site that would be suitable for a new permanent home for the Bournemouth centre. A lease has been agreed from April 2025, and following a refurbishment, we expect to move into the new Spa￿ by early June. Outreach services In 2024 we have continued to invest in delivering outreach serVi￿S in communities beyond our local centres, with the aim of expanding our demographic and gec*Jraphic reach. This has included our Sing 4 Life choirs, as well as the continued promotion of our digital service. During the year we took the decision to close our Andover l-day per w*k drop-in support session, due to low numbers. The clients were offered online servi￿5 and we also signposted them to other Ic(al organisations Recruiting new clients to our online Servi￿ has continued to be difficult. However, we continue to offer several services online, including a sound therapy group, a bi-weekly men's support group run in partnership with AFC Bournemouth, as well as one to one counselling sessions, We also host a thriving Facebook support group with over 300 members. Consequently we have increased the number of online SUPfK)rt sessions delivered by a third, to 1,362. We are aiming to increase the number of men uslng our services and are constantly evaluating who is engaging with what services. Our walking groups have proved a good way to encourage men to access services. Despite this, the proportion of men using our servi￿5 dropped to 26 % (2023: 280/0), so this is an area for continued focus. We are exploring how to use digitallonline to engage potential clients wffch a lighter touch offer of a supp)rt, and in 2025 will be launching a series of online tslks open to anyone. Daisy Buses Our two Daisy Buses in Southampton and Portsmouth continued to offer a vitsl Servi￿ for patients travelling from the Isle of Wight for treatment on the mainland. The Servi￿ is also provided to patients from Jersey under a contract with the States of Jersey Government and with the support of our long-term partner, Jersey Can￿r Trust. During the year we delivered a total of 15,248 individual Daisy bus joumeys (2023: 12,300). Sing for Life Choirs Wessex Cancer Support services are rooted in Iixal communities and this is particularly the case with our Sing for Life choirs, based in Totton, Cosham, Salisbury and Newport on the Isle of Wight. Singing can help lower stress, boost immunity and lung function and improve mental health, and our informal singing groups offer a supFK)rtive community that benefits many people affected by cancer. The choirs continued to perform in public at various Tesco bucket collections in 2024, raising money and awareness and spreading joy to shoppers. Performances during the year also included a number of Christmas engagements, such as a Christmas Tree festival and care home perforrnan￿, as well as our annual Christmas cOn￿rt fundraising event held in Titchfield in December. During 2024 our choir leader Sue Edmonds, who has been responsible for building the choirs over many Kvessex Call￿r Support Regiawed Loti)pany No. 05416) I I Page 8 ul 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 years, decided to take a step back from our Totton and Cosham choirs, to focus on the large Salisbury choir. We welcomed two new choir leaders for Totton and Cosham, who have settled in well with our memters. Communications and Marketing In 2024 we continued to roll out our new refreshed brand, which aims to more clearly articulate who we are and what we do, and be welcoming to people from the diverse communities in the region. Story-telling is an effective way for us to raise the profile of our work, with our marketing and seniices teams working together to identify people who are willing to share their own experience of cancer. We do not underestimate how hard thi5 can be and are deeply appreciative of our clients that support the charity in this way. Recognising resourcing challenges during the year, we have been focused on improving the way we use our data and measure our marketing activity. We have achieved key improvements in our communications, introducing a monthly newsletter for each of our four centres which have been well received, and increasing engagement rates for our Closer Look e-newsletter. We have been exploring the potential of paid digitsl channels, testing and measuring the impact of various different messaging. We continue to nurture pJsitive ￿latIOnShipS with local media which has offered numerous opportunities to promote the charity and our attivities across the region. The trustees recognise that strong communications and marketing for the charity is a key driver of growth and this is an area of focus in our five-year strategy from 2025 and beyond. Strategic priority 2: Our clients will receive high quality personalised support Everyone's experien￿ of can￿r is highly individual and there is no right or wrong way to feel, respond or behave. This is a central tenet of our servi￿, and we aim to offer SUPFM)rt that is personalised to the client. Anyone can self-refer to Wessex Cancer Support, and new clients are offered an initial app)intment with our wellbeing co-ordinator to discuss what SUPF()rt they might need. The output is a personalised support plan which could include a series of one to one services such as counselling or Reiki. In 2024 we took the decision to offer different ServI￿S one at a time, rather than concurrently, so that we are better able to measure the impatt, and this has been introduced at the beginning of 2025. At the end of the initial support prchJramme (usually around 6 months later), each client is offered a follow up meeting with the wellbeing co-ordinator to discuss whether any ongoing support is needed. Monitoring and evaluation During 2024 we have continued to capture feedback and analyse data to ensure we are successfully monitoring and evaluating service5. Information about how clients are feeling and coping is collected during their initial wellbeing assessment, and this is used as a benchmark to monitor and evaluate progress. We encourage clients to give feedback through QR codes displayed in each ￿ntre, and during 2024 we undertook a survey to clients to help inform our future strategy planning. We are pleased to report that during the year 99 % of clients rated the support they had received as Good or EX￿lIent (2023: 98%). Strategic priority 3: We will seek out meaningful strategic partnerships Wessex Can￿r Support services are a vital part of the local cancer provision. Since the charity was founded, Wessex Cantrr SupFK>rt Regist￿p.d Coinpany No. 05416311 Page 9 0142 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 we have worked with partner5 including the NHS and other charities to provide support services that complement cancer services offered elsewhere. Partnership working is an ongoing priority; we recognise it is crucial to ensure the best possible ServI￿S for people with cancer and their loved ones. In 2024 we continued to work with partners at both a region-wide and community level to better influence the local can￿r agenda and advocate for our clients. We work with the Wessex Can￿r Allian￿ (WCA) and I￿al can￿r Servi￿$, and our ￿0 and Director of Services represent the charity on key boards and working groups, including WCA'S Personalised Care Programme Board. During 2024 we were a partner on the delivery of the pilot Whateverit Takes projett. This was led by charity Help and Care and funded by NIHCR, and aimed to understsnd the needs of transgender people affetted by Can￿r. The final report is due to be shared with NIHCR in early summer 2025. In 2024 we continued to deliver some contracted counselling and therapy services on site at Southampton General, QA Hospital Portsmouth and the Royal Bournemouth hospital. We also renewed the long-standing contratt with States of Jersey to provide patient transport from local hotels to University Hospital Southampton. We have been informed by the States of Jersey that the contract will not be renewed in 2025 and funding will cease in August 2025. In early 2025 we have been pursuing funding for both this and our Portsmouth bus, through NHS channels, with encouraging results. During 2024 we have also explored oppjrtunities with the charity Maggie's which offers emotional and wellbeing support in a purpose-designed building in the grourKls of Southampton General Hospital. In early 2025 we have launched a series of Maggie's courses, to be delivered in collaboration with members of their team, to clients in our ￿ntre5 and online. strategic priority 4: Our charity will be financially stable, operate efficiently and attract and retain high quality staff and volunteers. Despite a very difficult year financially in 2024, we have managed to maintsin financial stability due to the reserves we designated to mitigate the impact of a year of reduced legacy income, combined with ongoing tight management of our operating costs. Legacies and Fundraising Income from legacies was £111,679. The trustees offer our sincere gratitude to everyone who cho)ses to donate to Wessex Can￿r Support by leaving a gift in their will of whatever size. Legacies are a vitsl source of income for the charity and while substantial, the total raised in 2024 was significantly lower than in the previous year. This dip in funding from legacies was refletted in the overall group deficit. Unfortunately, we also failed to achieve the targeted growth in other fundraising income streams, instead raising much less than in 2023. Once again, we have been impacted by several external factors, in particular the difficult market for recruiting and retaining staff and the general level of economic uncertainty brought on by the cost of living crisis and geo-political situation. The staff turnover has neTrssitated time spent inducting and settling new members of staff. In early 2025 we welcomed a new Direttor of Fundraising, Catherine Pri￿, who is focused on rebuilding our fundraising team and income streams. A particular focus for Catherine will be to estsblish robust connettions with both current and potential supporters, as we recognise this will be crucial to our success in the future. In addition, we recognise the n￿d to improve our management and analysis of data, work being supported by a new vOlunt￿r who is leading a dedicated dats review, working in partnership with Catherine. Despite the dip in our fundraising income performance in 2024, we remain optimistic that future growth will be possible. Among the highlights of the year was £22,000 raised through our annual Bournemouth Airshow event, and over £7,000 raised through our partnership with Harbour Hospitsls. Our beloved Swim for Hope WesseA tsncei Suppoil RpyisteiÉd CoiiipaFitr No. 054163] I Poge 10 DI 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and attounts foy the year ended 31 December 2024 event returned, and 27 intrepid people swam from Hurst Point near Lymington to Colwell Bay on the Isle of Wight, raising nearly £25,000. In December we were delighted to be joined by actor Sarah Parish and presenter Sam Fraser, as well as His Majesty's Lord-Lieutenant Nigel Atkinson at our annual Christmas carol concert in Titchfield. We launched a new carol concert event on the Isle of Wight which was a huge suc￿55, selling out all ticket5. Retail In 2024 we added a sixth shop to our retail operation. With all shops performing very strongly we saw a significant uplift in contribution to the charity. Our newest shop in the Westbourne area of Bournemouth was opened in April 2024, delivering £90,096 of sales in its first 9-months of trading, a key factor in the overall 249/0 increase in turnover in 2024. We are hopeful for Westbourne's potential and expect that in future the shop will continue to make a significant contribution to Wessex Cancer Support. Overall the shops achieved sales of £704,240 (2023: £567,468). This was the result of a continued focus on marginal gains across all our shops, with attention to quality stock rotation, excellent customer service, and a responsive approach to pricing and sales promotions. Following the implementation of a new digital Gift Aid system in 2023, we had expected to see growth in this area. However, we achieved only a marginal uplift on gift aid declarations, on 350/0 of sales (2023: 34 % ). Growth in this area will continue to be a focus in 2025. Overall costs also increased to £570,034 (2023: £463,096), due to setting up and running the Westbourne shop, combined with the impact of increases in the National Minimum Wage. Despite the higher costs, the overall contribution to the charity has increased by a remarkable third, to £130,750 (2023: £101,895). The success of our retsil operations relies on donations of second-hand goods, and we thank everyone who has given support either by donating or buying items. The Direttors also recognise the contribution of the retail team of staff and volunteers, who daily demonstrate an impressive dedication to their individual shop, and the charity as a whole. The performan￿ of our retail operations in 2024 confirms that our shops remain an important part of the charity, providing both income and a high street presence which raises the profile of our services. Wessex Cancer Support is reliant on voluntary income such as donations, gifts in a will, participation in fundraising activities, and sales and donations of second-hand goods in our shops. Manyi many individuals, organisations, clubs, schools and companies supported the charity during 2024 in a whole host of ways, and we are enormously grateful for that support. Our people The trustees acknowledge that a significant risk to the charity is the ongoing challenges around recruiting and retaining staff. This is common across many sectors and in the voluntary settor this extends to volunteers as well as paid staff. At Wessex Cancer Support we are reliant on volunteers to deliver our Se￿￿￿5, staff our shops and support fundraising. Volunteers are carefully vetted and trained and approximately 200 volunteers work across the organisation with our workforce of paid staff and some fr￿1an￿rs. During 2024 our Director of Organisational Effectiveness, who has responsibility for people-related issues, has undertaken a series of attivities and measures such as exit interviews, staff benefits review and a review of our training, to help us understand the issues more clearly, and better develop mitigations. Staff and volunteers are also regularly encouraged to offer suggestions and provide any other feedback both in person and through regular surveys. Wc'ssex (-21'opr SLJV)ricirt R￿glI[PlEA ( (Iini)any No. 05416311 Page 11 of42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 Following the r()sitive f&dback from our 2023 event, we held another full staff and volunteer away day in 2024. It was attended by the Majority of paid staff and 27% of our volunteers and was an Op￿rtUnIty to gather f￿dback and input into the future strategic plans. Feedback was positive with over 94 % of attendees rating the day as gocrt Registered Cimpany No. 0￿]6311 Page 16 Df 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 Adverse events Incidents that damage reputation andlor negatively impatt operations (including, fraud, supply chain disruption, major health and safety incidents, safeguarding and internal prO￿sS failures). Management.. We maintain a business continuity plan which is reviewed regularly. Regular financial rewrting and monitoring. Proattive whistleblowing Folicy and media management. Monitoring of key Suppliers, induding financial, and other due diligen￿ checks. Regular reviews and training on all policies and procedures, including safeguarding. Operational risks Computer system failures or adequacy of systems; loss of data/ dats breach. cyber security. Management. Cyber security awareness is embedded in the charity with regular staff and volunteer training, and we maintain accreditation of Qber Essentials. A Business continuity plan is regularly reviewed. We use Microsoft 365 and have outsourced our fT support. Poor volunteer recrLJitment and retentionl lack of volunteer competencies. Management.. Our people team works to ensure a consistent approach to volunteer recruitment, training, management and communication across the charity. High stsff turnover and recruitment challenges. Management.. During 2024 our people team has become more established, and is continuing to develop initiatives to improve our working policies and practices. We offer flexible working and annual salary awards. Regular staff appraisals with clear objectives. EDI strategy and monitoring. Regular feedback from employees and exit inteNiews with leavers. Financial Income, expenditure and cash flow. Management.. Budgets set annually and monthly monitoring of actuals to identify actions needed. Over-dependency on legacy as the most substantial income stream Management.. A new Fundraising Director in post Sin￿ January 2025 who has focused on establishing a fundraising strategy and rebuilding our fundraising team to further diversify income. Priority work taking place on improving management and analysis of dats. In addition, we take a pragmatic approach to designation of reseNes which helps to mitigate the risks of unpredictable legacy income. Investments presenting exposure to financial risk and market movements. Management.. Responsible investment approach with regard to best practice in Environmentsl, Social and Governan￿ (ESG) issues, and in accordance with the charity's own charitable mission and values. Expert advice informs investment and treasury activities. Oversight of investment and treasury activities by our Finance & Audit Committ￿, who monitor compliance and performance. Our approach to safeguarding At Wessex Cancer SupFK)rt we have Safeguarding policies and prccedures for Adults and Children which reflect current legislation such as The Mental Capacity Act 2005, Safeguarding Vulnerable Groups Att 2006 and the Care Act 2014. The Multi-Agency Safeguarding Adults Policy and Guidance (June 2020) developed by the Safeguarding Adults Boards in Hampshire, Southampton, Isle of Wight and Portsmouth, informs our training for staff and volunteers. Our Director of Organisational Effettiveness is our Safeguarding Lead, supported by the Director of Servi￿5 who provides continued oversight and review of all safeguarding Wessex Can￿r Support Registered Company No. 054 16311 Page 17 of42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 concerns. The Governance, Risk and HR Committee retrives regular UFdates on safeguarding matters from the safeguarding lead, and reviews our safeguarding policy annually. Our approach to fundraising Wessex Cancer Support is a member of the Fundraising Regulator and adheres to fundraising codes of practi￿. We employ a team of Fundraisers who work across the region. During 2024 we continued to develop a broader fundraising portfolio to mitigate the risks presented by an uncertain external environment. On occasion we use external agencies to deliver fundraising attivities. All attivity is delivered to Servi￿ level agreements which are monitored through regular meetings, mystery shopping and regular review of feedback and any complaints. Agencies are contractually required to ensure all fundraising activity is in accordance with all applicable legal requirements and the relevant binding codes of practi￿ issued by the Fundraising Regulator. Professional fundraising agencies must have clear and up to date policies in place to protett vulnerable people and other members of the public from unreasonable behaviour. In 2024 no complaints atK)ut Wessex Can￿r Support fundraising practices or activities were received by the Fundraising Regulator. Trustees, responsibilities in relation to the financial statements The trustees (who are also directors of Wessex Cancer Support for the purp)ses of company law) are responsible for preparing the trustees, report and the financial statements in accordan￿ with applicable law and United Kingdom Accounting Stsndards (United Kingdom Generally Accepted Accounting Practice). Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial ststements unless they are satisfied that they give a true and fair view of the stste of affairs of the charitable company and the group and of the incoming resources and application of resour￿, including the income and expenditure, of the charitsble group for that period. In preparing these financial statements, the trustees are required to: select suitsble accounting policies and then apply them consistentlyi observe the methods and principles in the Charities SORP (FRS102); make judgments and accounting estimates that are reasonable and prudent; state whether applicable UK Accounting Standards have been followed, subjert to any material departures disclosed and explained in the financial statements; prepare the financial ststements on the going concern basis unless it is inappropriate to presume that the charitable group will continue in operation. The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company and the group's transattions and disclose with reasonable accuracy at any time the financial position of the charitable group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitsble company and the group and hen￿ for taking reasonable steps for the prevention and detection of fraud and other irregularities. Provision of information to auditor Each of the persons who are trustees at the time when this trustees, report is approved has confirmed that: so far as that trustee is aware, there is no relevant audit information of which the charity's auditors are unaware, and Wessex Can￿r Support Registered Company No. 05416311 Page 18 of 42 Wessex Cancer Support (Registered Company No: 05416311) Annual report and accounts for the year ended 31 December 2024 each trustee has taken all the steps that ought to have teen taken as a trustee in order to be aware of any information needed by the charity's auditors in connection with preparing their report and to establish that the charity's auditors are aware of that information. Auditor During 2024 we underto)k a retendering of our audit and as a result we reappointed Azets Audit Services as auditors to the group. In accordance with section 485 of the Companies Act 2006, a resolution proFK)sing that they be re-appointed will be put at the Annual General M￿ting. This report was approved by the trustees on 14 May 2025 and signed on their behalf by Diane Cutler, Chair of Trustees Wessex CaiTr￿r Sijpport IleqisleiEd C￿11[>31)Y Plo. 05416311 Page 19 of 42 Wessex Cancer Support (Registered Company No: 05416311) Independent auditor'5 report to trustee5 of Wessex Cancer Support Independent auditor's report to the trustees of Wessex Cancer Support Opinion We have audited the financial statements of Wessex Cancer Support (the 'parent charitsble company? and its subsidiary (the 'group') for the year ended 31 De￿mber 2024 which comprise statement of financial activities, balanTr sheet, statement of cash flows, and notes to the financial statements, including significant accounting pK)licies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Stsndard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practi￿). In our opinion the financial statements.. give a true and fair view of the state of the group's and parent charitable company's affairs as at 31 December 2024, and of the group's incoming resources and application of ￿our￿S, including its income and expenditure, for the year then ended. have been properly prepared In accordan￿ with United Kingdom Generally AC￿pted Accounting Practi￿. and have been prepared in accordan￿ with the requirements of the Companies Act 2006. Basis for opinion We conducted our audit in accordance with International Stsndards on Auditing (UK) (ISAS (UK)) and applicable law. Our reS￿nSIbIlitieS under those standards are further described in the auditor responsibilities for the audit of the financial ststements section of our repjrt. We are independent of the group and parent charitable company in accordan￿ with the ethical requirements that are relevant to our audit of the finanaal statements in the UK, including the FRC'S Ethical Stsndard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Conclusions relating to going concern In auditing the financial statements, we have conduded that the trustees, use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group and parent charitable company's ability to continue as a going con￿rn for a period of at least bNelve months from when the financial ststements are authorised for issue. Our responsibilities and the responsibilities of the trustees with respett to going con￿rn are described in the relevant sections of this report. Other information The other information comprises the information included in the trustees, annual report, other than the finanaal statements and our auditor's reFKirt thereon. The trustees are resp)nsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly ststed in our report, we do not express any form of assuran￿ conclusion thereon. Our responsibility is to read the other information and, in doing 50, consider whether the other information is materially inconsistent with the financial ststements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent Vessel IcDcer Supplbrt FteglStei"ed Loii Iyaiii No. Qjli 16- 11 Page 20 0142 Wessex Cancer Support (Registered Company No: 05416311) Independent auditor's report to trustees of Wessex Cancer Support material mi5Statements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have perfomied, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. Opinions on other matters prescribed by the Companies Act 2006 In our opinion, based on the work undertaken in the course of the audit: the information given in the trustees, ￿￿K)rt, which indudes the strategic rewrt and the directors, report prepared for the purposes of company law, for the financial year for which the financial statements are prepared is consistent with the financial statements; and the strategic report and the direttors, report induded within the trustees, report have been prepared in accordance with applicable legal requirements, Matters on which we are required to report by exception In the light of the knowledge and understsnding of the group and parent charitsble company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the direttors, report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: adequate accounting records have not been kept by the parent charitsble company, or returns adequate for our audit have not been received from branches not visited by us; or the parent charitsble company's finanaal statements are not in agreement with the accounting records and returns. or rtain disclosures of trustees, remuneration specified by law a￿ not made; or we have not received all the information and explanations we require for our audit. Responsibilities of trustees As explained more fully in the trustees, resp)nsibilities statement, the trustees (who are also the directors of the parent charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial 5tstements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the group and parent charitable company's ability to continue as a going COn￿rn, disdosing, as applicable, matters related to going con￿rn and using the going con￿rn basis of accounting unless the trustees either intend to liquidate the group or parent charitable company or to Trase operations, or have no realistic alternative but to do so. Auditor responsibilities for the audit of the financial statements Our objectives are to obtsin reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's reFK)rt that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordan￿ with ISAS (UK) will always detect a material misststement when it exists. Wessex Can￿¥ Support Registered Comiiany No. 054J6311 Page 21 0142 Wessex Cancer Support (Registered Company No: 05416311) Independent auditor's report to trustees of Wessex Cancer Support Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be exFected to Influen￿ the economic decisions of users taken on the basis of these financial ststements. Extent to which the audit was considered capable of detecting irregularities, including fraud Irregularities, including fraud, are instan￿5 of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Finanaal Reporting Council's website, to detect material misstatements in respect of irregularities, induding fraud. We obtain and update our understanding of the entity, its attivities, its control environment, and likely future developments, induding in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtsin audit eviden￿ that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud, In restM)nse to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included: Enquiry of management and those charged with govemance around actual and ￿tentIal litigation and claims as well as actual, suspected and alleged fraud; Reviewing minutes of meetings of those charged with governance; Assessing the extent of Complian￿ with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the company through enquiry and inspection; Reviewing financial ststement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations. Performing audit work over the risk of management bias and override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transattions outside the normal course of business and reviewing accounting estimates for indicators of potential bias. Because of the inherent limitstions of an audit, there is a risk that we will not detect all irregularities, including those leading to a material rnisststement in the financial statements or non-compliance with regulation. This risk increases the more that Complian￿ with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to tecome aware of instances of non-compliance. The risk of not detetting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Use of our report This report is made solely to the charitable company's members, as a body, in accordan￿ with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might State to the charitable company's members those matters we are required to state to them in an auditorfs repK)rt and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to Wessex (Ancer Support Registered Coinpany No. 05416311 Page 22 Df 42 Wessex Cancer Support (Registered Company No: 05416311) Independent auditor's report to trustees of Wessex Cancer Support anyone other than the charitable company and the tharitable company s members as a body, for our audit work, for this report, or for the opinions we have formed. Signed by Jon Noble, Senior Statutory Auditor For and on behalf of Azets Audit Services ststutory Auditor Athenia House 10 - 14 Andover Road Winchester Hampshire, United Kingdom S023 7BS Date 2oLS Wessex Cancer Support Registered Coiiii)any No. L154 16311 Page 23 0142 We55ex Cancer Support (Registered Company No: 05416311) Consolidated Statement of Financial Activities (including income and expenditure account) for the year ended 31 December 2024 Consolidated statement of financial activities (including income and expenditure account) for the year ended 31 December 2024 Unrestrlctod Funds Deslgnated Fund$ Restrlcted Funds Total Funds Year to 31-12-24 Total Funds Year to 31-12-23 Note Income: Donatlons Legacles Ath￿es for ralslng funds other Income Investrnent Incom• 243,075 111,679 955,851 59,183 302,258 111,679 955,851 347,243 562,934 955.443 6,413 40,426 24,545 1,335,150 24,545 1,394,333 Total Income 59,183 1,912,459 Expèndlture Costs of ralslng funds: Costs of ralslng voluntsry Incom• Costs of athvltles for ralslng funds Expendlture on Charltable actlvltles: Care Eduutlon io io 279,664 570,034 279,664 570,034 326,561 463,096 12 12 1,089,678 26,295 194,1)42 5,270 1,283,720 31,565 1,208,822 io,oi? Total Exp•ndltur• 1965,671 199 312 2 164 983 2 008 496 Net Income before net (losses)Igalns on Inv•stm•nts and tax Nrt galnsl(Ioss•s) on Investh)ents Taxatyon Net Incomlng r••ourc•s before transfers (630,521) (140,129) (770,650) (96,037) 16 25 178,790 178,790 62,830 3,741 (455,187) (140,129) (595,316) (36,948) Transfers 21122 340,OS2 (341,946) {341,946) 1,894 Net movement In funds for the year Fund balances brought forward at l January 2024 Fund balances carrled forward at 31 December 2024 (115,135) {138,235) (595,316) (36,948) 1,505,947 1,200,000 300,902 3,006,849 3 043 797 1,390,812 858,054 162,667 2,411,533 3 006 849 The statement of financial activities includes all gains and losses recognised in the year. All incoming resources and reSoUr￿S expended derive from continuing attivities. Wessex Can￿r Support Registe￿ C(mpany No. 05416311 Paoe 24 of 42 Wessex Cancer Support (Registered Company No: 05416311) Consolidated Statement of Financial Activities (including income and expenditure account) for the year ended 31 December 2023 Consolidated statement of financial activities (including income and expenditure account) for the year ended 31 December 2023 Unrestrlcted Deslgnated Restrlcted Funds Funds Funds Total Funds Yearto 31-12-23 Note Income: Donation5 Legacies Artivities for raising funds Other income Investment income 220,305 562,934 955,443 6,413 40,426 126,938 347,243 562,934 955,443 6,413 40,426 Total income 1785 521 126 938 1912 459 Expenditure Costs of raising funds: Costs of raising voluntary income Costs of artivities for raising funds Investment management costs 10 10 326,561 463,096 326,561 463,096 Expenditure on Charitable activitieg: Care Educatlon 12 12 747,161 9,303 137,623 213 324,038 501 1,208,822 10,017 Total Expendlture 1546 121 137 836 324 539 2 008 496 Net Income before net (losses)Igaln$ on Investments and tax Net galnsl(losses) on Inv•stm•nts Taxatlon Net Incomlng resources before transfers 239,400 (137,836) (197,601) (96,037) 62,830 3,741 36,948 16 25 62,830 3,741 137,836 197,601 Transfers 21122 137,836 153,588 Net movement In fund5 for the year Fund balances brought forward at l January 2023 Fund balances carrled forward at 31 December 2023 314,239 (351,189) (36,948) 1 191706 1200 000 652 091 3 043 797 1,505,947 1,200,000 300,902 3,006,849 The statement of financial activities includes all gains and losses recogni5ed in the year. All incoming resources and resources expended derive from continuing activities. Wessex Caiicer SiJi)port Reglslered l.onip¢Jny No. 05416311 Wessex Cancer Support (Registered Company No: 05416311) Consolidated and Charity Balance Sheets as at 31 December 2024 Consolidated charity balance sheets as at 31 December 2024 Group Charlty 2024 2023 2024 2023 Flxed assets Tangible assets Investments 15 16 76,870 1998 783 77,551 1461758 42,750 1998 785 57,138 1461760 2 075 653 1539 309 2 041535 1518 898 Current assets Debtors due wlthln one year Cash at bank and In hand 17 102,543 369,133 314,123 1,295,631 175,217 295,003 373,225 1,215,903 471,676 1,609,754 470,220 1,589,128 Credltors: amounts falllng due wtthln one year 18 138 914 100 224 101177 Net current assets 342,636 1,470,840 369,996 1,487,951 Total assets less current Ilabllltles 2,418,289 3,010,149 2,411,531 3,006,849 Credltors: amounts falllng due after more than one year 19 Net assets 2 411533 3 006 849 2 411531 3 006 849 Funds Restrfrted Unrestricted - Deslgnjted Unrestrfcted 21 22 22 162,667 858,054 1,390,812 300,902 1,200,000 1,505,947 162,667 858,054 1,390,810 300,902 1,200,000 1,505,947 22 2411533 3 006 849 2 411531 3 006 849 The financial statements on pages 24 to 42 were approved by the Board of Trustees on 14 May 2025 and signed on their behalf by Martin Miles W￿SeX Cancel. Support Registered Company No. 054J6311 26;.T42 Wessex Cancer Support (Registered Company No: 05416311) Consolidated Statement of Cash Flows for the year ended 31 December 2024 Consolidated statement of cash flows for the year ended 31 December 2024 Group Note 2024 2023 Cash inflow from operating activities 26 562 897 Cash flows from investing artivities Investment income 24,S45 40,426 Purchase of tsngible fixed a55ets 15 {29,911) (32,645) Investment in fixed asset investments 16 (355,789) (1,398,791) Net investment income ￿Invested 16 (2,446) Net Gish flow from Investlng actlvitie$ 363 601 1391010 Decrease In cash and cash equivalents In the year 926 498 1120 232 Cash and cash equivalents at the beginning of the year 1,295,631 2,415,863 Total cash and cash equivalents at the end of the year 369 133 1295 631 Represented by: Cash at bank 369,133 1,295,631 369 133 1295 631 Statement of changes In Det debt - table loa SORP Analysts of changes In net debt: At 01-01-24 At 31-12-24 Gish flows Cash at bank 1295 631 926 498 369 133 1.295,631 (926,4981 369.133 Wessex Concer SLlI)POrt Registered C(4npany No. 05416311 Page 27 of 42 Wessex Cancer Support (Registered Company No: 05416311) Notes forming part of the financial ststements for the year ended 31 December 2024 Notes forming part of the financial statements for the year ended 31 December 2024 Company Status Wessex Can￿r Support is a company limited by guarantee (number 05416311) incorporated in England & Wales and registered with the Charity Commission (number 1110216). The members of the company are the trustees who are named on the first page of the statutory accounts. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £10 per member of the charity. Principal accounting policies Basis of preparation The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practi￿ applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective l January 2019) (Charities SORP (FRS102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Companies Act 2006. The Charity is a public benefit entity as defined by FRSIO2. The financial statements are prepared under the historical cost convention in sterling, which is the functional Curren￿ of the charity, as modified by the inclusion of investments at market value. Monetary amounts in these financial statements are rounded to the nearest pound. Critical a￿OUntIng estimates and judgements In the application of the accounting policies, the Trustees are required to make judgements, estimates and assumptions abjut the carrying amounts of assets and liabilities that are not readily apparent from other sources. As the estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant, actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial ststements: Depreciation Debt recoverability Legacy income reccrfjnition Going concern At the time of approving the financial ststements, the trustees have a reasonable expectation that the Group has adequate resources to continue in operational existentr for the foreseeable future. Thus the accounts are prepared on a going concern basis. Group financial statements The statement of financial activities and balance sheet consolidate the financial statements of the charity, and its subsidiary undertaking. The ￿sUltS of the subsidiary are consolidated on a line-by-line basis. A separate ststement of financial attivities and income and expenditure account are not presented for the Wessex Cancer Swport RegislwEd C(¥npany No. 05416311 Page 28 0142 Wessex Cancer Support (Reglstered Company No: 05416311) Notes forming part of the financial statements for the year ended 31 December 2024 charity itself following the exemptions afforded by section 408 of the Companies Att 2006. The parent company's result for the financial year was a deficit of £595,318 (deficit for the year to 31 December 2023: £37,561.) Charitable funds Unrestritted funds are available for use at the discretion of the Trustees in furtheran￿ of the general objectives of the charity and which have not been designated for other purposes. Designated funds have teen set aside by management for particular operational and strategic purposes. Restricted funds are funds which are to be used in accordance with specific restrictions IM￿sed by donors or which have keen raised by the charity for particular purFoses. The cost of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements. Incoming resources Donations and attivities for generating funds are reccrfjnised in the period in which the charity re￿iVeS the income or when there is a reasonable assurance of receipt. Income is deferred only when the charity has to fulfil conditions before tecoming entitled to it or where the donor has specified that the income is to be expended in a future period. Legacies are included in the statement of financial activities on a receivable basis, teing recognised at the point of notification of grant of probate when the charity's interest can be measured or estimated with sufficient reliability. Investments and investment income Investments are a form of basic financial instrument and initially recognised at their transaction value and subsequently measured at their fair value as at the balan￿ sheet date using the closing quoted market pri￿. Gains and 1055es on investments both realised and unrealised are included in the statement of financial attivities. All income arising on investments is accounted for on a receivable basi5. Resources expended Expenditure is recognis8J once there is a legal or constructive obligation to make payment to a third party, it is probable that settlement will be required, and the amount of the obligation can be measured reliably. All expenditure is accounted for on an accrual basis. All expenses including support costs and governance costs are allocated to the applicable expenditure headings. The costs of generating funds are those costs incurred in attratting voluntary income, and those incurred in trading attivities to raise funds. Support costs, which include the ￿ntral Offi￿ funttions such as general management, payroll, administration, budgeting and accounting, information technolchJy and human resources are allocated across the categories of the costs of generating funds, charitable activities and governan￿ costs. Support costs are direttly attributed where possible. Where this is not wssible, they are apF()rtioned on the basis of number5 of staff employed and hours in different operation areas of the charity. Irrecoverable VAT is charged a5 a cost to the Ststement of Financial attivities (within the appropriate category as noted above). Wessex Cancer SLPPOrt Registered Cixnpan¥ No. 05416311 Paqf 29 0142 Wessex Cancer Support (Registered Company No: 05416311) Notes forming part of the financial ststements for the year ended 31 December 2024 Tangible fixed assets and depreciation Tangible fixed assets are stated at cost less depreciation. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost less their estimated residual value on a straight-line basis over their expected useful economic lives as follows: Leasehold Propety Motor Vehicles Fixtures and Fittings over length of lease between 10 % and 200/0 per annum between 150/0 and 33 % per annum No as*t under £500 is capitslised. Retirement benefits Payments to the group defined contribution ret1￿ment benefit scheme are charged as an expense as they fall due. Financial Instruments The group has elected to apply the provisions of Settion 11 'Basic Financial Instruments, and Settion 12 'Other Financial Instruments Issues, of FRS 102 to all its financial instruments. Financial instruments are recognised in the Group's balance sheet when the Group become party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial ststements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultsneously. Operating leases Rental costs under operating Seases a￿ charged to the Ststement of Financial Artivities as incurred over the period of the leases. Debtors Trade and other debtors are recognised at the settlement amount due. Prepayrnents are valued at the amount prepaid net of any discounts due. Cash at bank and in hand Cash at bank and cash in hand includes cash and short term highly liquid investments with a maturity of thr￿ months or less from the date of acquisition or opening of the deposit or similar account. Creditors Creditors are recognised where the group has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors are normally recognised at their settlement amount after allowing for trade discounts due. Taxation The charity is exempt from corporation tsx on its charitable attivities, Taxation for the trading subsidiary is accrued on its taxable profit. The subsidiary company makes qualifying donations of all tsxable profits to the charity and thus generally d¢)es not incur corporation tax. wesse.x (.dnL&I Suppoi i fleqistE.red Ciiiiiiiany No Q.')416311 Page 30 0142 Wessex Cancer Support (Registered Company No: 05416311} Notes forming part of the financial statements for the year ended 31 De￿mber 2024 Legacies There is inherent uncertainty in the probate valuation of estates as a result of the nature of underlying assets and liabilities, the time that elapses between probate and closure, and other contingencies that attend the estate. Legacies are recognised at the point of notification of grant of probate when it can be measured or estimated with sufficient reliability. A total amount of legacy income of £111,679 (2023: £562,934) was reccgnised in the year, and a balan of £6,044 (2023: £238,147) was included within debtors as at the year end (see note 17).In addition, the charity was entitled to further legacies whose value could not be estimated with sufficient reliability to reccgni* in the year, in accordan￿ with FRS 102 and the Charities, SORP. Activities for raising funds Unrestrlrted Funds Restrlcted Funds Total 31-12-24 Fundralslng events and appeals Retsll Income (see note 7) 251,611 704,240 955,851 251,611 704,240 955,851 Unrestrlcted Funds Restrfcted Funds Total 31-12-23 Fundralslng events and appeals Retsll Income (see nots 7) 387,975 567 468 955,443 387,975 567 468 955,443 Other income Unrestrlrted Funds Restrlcted Funds Totsl 31-12-24 Insurance clalms Lease surrender Unrestrlcted Funds Restrlcted Funds Total 31-12-23 Insurance claims Lease Surrender 1,264 5,149 6,413 1,264 5,149 6,413 Wessex Cancel. SLlPPOrt Regist￿1 Coiiipai)y No. 05416311 Wessex Cancer Support (Registered Company No: 05416311) Notes fomiing part of the financial statements for the year ended 31 December 2024 Investment income Total 31-12-24 2024 Unrestrlded Funds Restrlcted Funds Income from listed Investments Bank Interest 24,543 24,545 24,543 24,545 Restrlcted Fund5 Total 31-12-23 2023 Unrestrlcted Funds Income from Ilsted Investments Bank Interest 40,425 40,426 40,425 40,426 Income from trading activities of subsidiary The charity has a wholly owned trading subsidiary, Wessex Can￿r Support Trading Ltd, which is incorF(Irated in the UK, and whose principal activity is to undertake the trading activities of Wessex Can￿r Support. Its trading results for the year, as extracted from the audited financial ststements, are summarised below: Profrt and LO￿ Account Total 31-12-24 Total 31-12-23 Rltsll Incom• Cost of Sal•s Gross Profft 704,240 567,468 685,146 547,805 Exp•ns•s Other Incorne Profft before taxatlon (550,940) (443,4331 134,206 105,636 Tax on proflts {3,456) (3,741) Profft for th• Flnanclal Y•ar 130,750 101,895 Retslned earnlng brought fonvard Amount olft alded to the Trust Retalned profft 130 750 101895 Wessex Canier SLprxJrt Registered C(￿l￿anY No. 05416311 Wessex Cancer Support {Registered Company No: 05416311) Notes forming part of the financial statements for the year ended 31 December 2024 Total expenditure Total 31-12-24 2024 staff Costs Depreclatlon Other Costs C05t of genern￿ng funds (Nots 10) Provision of sep4los (Nots 12) Support costs (Note 11) Governance (Note I l) 498,298 505,963 286,471 7,135 344,265 310,737 136,356 849,698 816,700 23,457 446,284 1331656 802 735 2 164 983 Total 31-12-23 2023 staff Costs Depreclatlon Other Costs Cost of genera￿ng funds (Note 10) Provlslon of servlces (Note 12) Support costs (Note 11) Govemance (Note I l) 400,137 471,440 216,649 10,794 378,726 306,578 159,219 789,657 778,018 395,898 20,030 1119 176 858 496 2 008 496 Net Incoming Resources for the Year Group Thls has been ststed after charglng; 2024 2023 Operntlng lease rentsls (Bulldlngs) Depreclatlon Audltors remunwatlon Audit Fee Other SeNlces 260,067 30,592 243,235 30,824 13,250 1,150 17,443 210 w￿SeX Cancer Swix)rt Registered Lonii)any No. OJ416311 ,33,:42 Wessex Cancer Support (Registered Company No: 05416311) Note5 formin9 part of the financial statements for the year ended 31 December 2024 10. Cost of generating funds Unrestrlcted Funds Restrfcted Funds T¢)tal 31-12-24 Voluntary Income Fundra15ing staff costs General fundraising costs Charity organlsed event costs Advertising and publicty 186,961 51,882 34,111 6,710 186,961 51,882 34,111 6,710 Tradlng costs: Stsff costs Other 311,337 258 697 570 034 849 698 311,337 258 697 570 034 Unrestrlcted Funds Restrlcted Funds Total 31-12-23 Voluntary Income Fundralsing staff costs General fundrnlslng costs Charity organi5ed event costs AdvértlsSng and publlclty 185,537 36,424 65,895 185,537 36,424 6S,895 326 561 326 561 Tradlng costs: Staff costs other 214,600 248 496 463 096 789 657 214,600 248 496 463 096 789 657 Charitsble activities support costs are further analysed in note 11 and allocated 980/0 (2023: 98 % ) Care and 2% (2023: 20/0) Education. 11. Allocation of support and governance cost5 Staff Costs 327,395 110,186 21,564 4,606 11,377 286,471 110,186 21,564 4,606 40,924 Tlme Usage Usage Usage Usage Usage Computer Costs Legal Fees Aud Depreclatlon 11,377 23,457 498 585 Wessey Cancer 5LPPOrt Reaistered C(M￿n¥ No. 05416311 Pa 34,42 Wessex Cancer Support (Registered Company No: 05416311} Notes forming part of the financial statements for the year ended 31 De￿rnber 2024 Staff Costs Office Costs Computer Costs Legal Fees Audit Depreciation 247,599 132,052 20,792 6,375 13,973 20,030 216,649 132,052 20,792 6,375 30,950 Time Usage Usage Usage Usaje Usage 13,973 20,030 395 898 12, Analysis of expenditure on charitable activitie5 Provlslon of servlces Support costs Governance (note 11) Total 31-12-24 Care Educatlon 795,107 21,593 816,700 437,358 8,926 446,284 Sl,255 1,046 52,301 1,283,720 31,565 1,315,285 Provlslon of servlces Unrestrlcted Funds Restrlcted Funds Total 31-12-24 Counselllng and Support Complementsry therapy Health education 547,687 53,378 16,323 617,388 176,810 17,232 5,270 199,312 724,497 70,610 21,593 816,700 Provlslon of servlces Support costs Governance (note 11) Total 31-12-23 Care 776,817 1,201 778,018 387,980 7,918 395,898 44,025 898 44,923 1,208,822 10,017 1,218,839 Educatlon Provlslon of servlces Unrestrlcted Funds Deslgnated Funds Restrfcted Funds Total 31-12-23 Counselllng and Support Complementsry therapy Heath education 287,402 27,754 487 315,643 125,503 12,120 213 137,836 295,502 28,536 501 324,539 708,407 68,410 1,201 778,018 Wessex Cancer Support Registwed C(dnpany No. 05416211 35 ,142 Wessex Cancer Support (Registered Company No: 05416311) Notes forming part of the financial statements for the year ended 31 December 2024 13. Staff costs Unrestrfcted Funds Restrlcted Funds Total 31-12-24 2024 Salarles National Insurance Pension costs 1,104,623 80,394 116,753 6,079 1,221,376 86,473 1207 054 124 602 1331656 Unrestrlcted Funds Restrfcted Funds Total 31-12-23 2023 Salaries National Insurance Pension costs 898,528 71,353 119,615 8,715 1,018,143 80,068 988 534 130 642 1119 176 The average monthly number of employees during the year was 66 (2023: 55) and the average monthly number of full time equivalent employees during the year was 35 (2023: 33). One employee received remuneration of betNeen £90,000 and £IOO,000 per annum during 2024. In the prior year, one employ￿ received remuneration between £80,000 and £90,000. The key management personnel of the group comprise the Trustees, the Chief Executive, Director of Operational Effectiveness, Director of Fundraising and Communications, Director of servi￿5, Director of Finan￿ and Director of Retail. They received remuneration and benefits totaling £348,094 (2023: £303,017) and pension contributions of £14,423 (2023: £13,296). The 2023 figures disclosed relating to higher paid employ￿5 and key management personnel have been reststed, to ensure full employment benefits have been accurately presented. Pension costs outstanding at the year-end were £4,452 (2023: £3,268). There were no redundancy payments made during the year (2023: £nil). The charity also acknowledges the help of part time volUnt￿rS on a regular basis and various other volunteers on an ad hoc basis, without which the Wessex Cancer Support could not operate effectively. 14. Trustees, remuneration and expenses No Trustee re￿iVed any remuneration during the year (2023.. £nil). Two trustees received reimbursement of £431 (2023: £208) for travel expenses. Wessex Cancer Support Registered Company No. 0￿16311 Page 36 af 42 Wessex Cancer Support (Registered Company No: 05416311) Notes forming part of the financial statements for the year ended 31 December 2024 15. Tangible fixed assets Leasehold property Motor vehbcles XtUr￿ & frttlngs Total At 1st January 2024 Additions Disposals At 31st December 2024 322,304 25,650 14,274 138,193 15,637 486,147 29,911 153 830 516 058 Depreciation At 1st January 2024 Charge for the period Disposals At 31st December 2024 284,866 8,169 25,649 1,665 98,081 20,758 408,596 30,592 293,035 27,314 118,839 439,188 Net book value At 3 1st December 2024 At 31st December 2023 Charity tangible fixed asgets Leasehold property Motor vehlcles xtures & flttlngs Total Cogt At 1st January 2024 Additions Disposals At 3 1st December 2024 188,352 25,649 99,625 9,069 313,626 9,069 188 352 108 694 322 695 Depreciation At 1st January 2024 Charge for the period Disposals At 31st December 2024 157,617 6,599 25,649 73,222 16,858 256,488 23,457 164 216 279 94S Net book value At 31st December 2024 At 31st De￿mber 2023 Wessex Cancer Support Regiaered CM)pany No. 05416311 P8.1 37 42 Wessex Cancer Support {Registered Company No: 05416311) Notes fomiing part of the financial statements for the year ended 31 December 2024 16. Fixed asset investments Group Charlty 2024 2023 2024 2023 Flxed asset Investments at market value: Investment portfolio at l January 2024 Addttlons at Cost Dmdend and Interest Incom• net of fees N•t Invostment galnsl(loss•s) 1,461,758 355,789 2,446 178,790 1,998,783 136 1,398,791 1,461,760 355,789 138 1,398,791 62,830 1461,758 178,790 1,998,785 62,830 1,461760 Hlstorlcal Cost Inv•stment pothllo at cost at 31 Oecemb•r 2024 1,835,841 1,398,791 1,835,841 1398,791 Subsidiary company: The charity owns 2 ordinary shares of £1 representing 100 % of the issued share capitsl of Wessex Can￿r Support Trading Ltd (Company number 02729745) The company's net assets at 31 December 2024 were £2 (2023: £2) Group Charlty 2024 2023 2024 2023 Portfollo Includ•s: Sara55n EndobYm•nt Fund Class A ACC ICS.Sterlln9 Uquldty Fund . Acc 51 Uoyds Banklng Group lop Ordlnary shares 1,463,209 535,280 26 1,200,820 260,914 24 1,463,209 535,280 26 1,200,820 260,914 24 1.998,515 1,461,758 1,998,515 1,461,758 Unllst•d W•wx C)nc•r Support Tradlng Ltd Cash and sethwnents F•ndlng held 0$ pDrt of thè Investment portfollo 268 268 1,998,783 1,461,758 1,998,785 1,461760 17. Debtors Group Charfty 2024 2023 2024 2023 Amounts falllng due wlthln one year Trade debtors Prepayments and accrued Incorne LegacSes accrued Amounts due (to)1 from subsidiary other debtors 3,361 78,882 11,348 52,861 238,147 599 32,005 11,348 28,208 238,147 88,063 7,459 373,225 14,256 102,543 11,767 314,123 6,232 44,467 We55ex Cancel SLlI)POrt Registered Cor71pany No. 0541b311 Page 38 0142 Wessex Cancer Support {Registered Company No: 05416311) Notes forming part of the financial statements for the year ended 31 December 2024 18. Creditors.. amounts falling due within one year Group Charlty 2024 2023 2024 2023 Trade credito Accruals Deferred Income Taxation and soclal secur other credltors 39,253 28,016 27,126 12,029 22,616 129,040 49,278 30,070 4,458 20,975 34,133 138,914 29,984 19,601 27,126 8,274 15,239 100,224 38,493 17,766 4,458 17,807 22,653 101,177 Group & Charlty 2024 2023 Deferred Income at stsrt of year Resources deferred durlng the year Amounts rel￿Sed from previous years 4,458 27,126 (4,458) 29,332 4,458 (29,332) Deferred Income at end of year 19. Creditors: amounts falling due after more than one year Group Charlty 2024 2023 2024 2023 D•f•rr•d taxatlon 6,756 3,300 6,756 3,300 20, Financial commitments At 31 December the group had the following commitments under non-cancellable property leases., Group Charlty 2024 2023 2024 2023 Payable; Under l year Bet￿een 2 to 5 years Over 5 years 194,258 218,525 211,904 222,595 64,880 38,593 90,067 56,000 459 951 434 499 104 741 146 067 Wessex Cancer Supi>ort Registered Coii)pany No. 05416311 Pagc 39 Of 42 Wessex Cancer Support (Registered Company No: 05416311) Notes forming part of the financial statements for the year ended 31 December 2024 21. Restritted funds (Group & Charity) Balance 1-1-24 Movement In resources Transfers (d) Incoming Outgolng Balan 31-12-24 (a) Centres (b) Patient Transport (c) Outreach programmes Total restrlcted funds 232,966 21,882 46,054 300,902 43,150 16,033 (126,894) (25,398) 47,020 (199,312) 928 150,150 12,517 966 59,183 1,894 162,667 Balance 1-1-23 Movement In resources Transfers (d) Incomlng Outgolng Balance 31-12-23 (a) Centres (b) Patlent Transport (c) Outreach programmes Total restrlcted funds 506,961 5,006 140,124 652,091 101,131 25,807 (221,537) (153,588) (8,932) 94,070 324,539 232,967 21,881 46,054 300,902 153,588 (a) Specific funding for our centres which provide emotional health and wellbeing support to people with cancer and their loved ones. Support servi￿$ provided in ￿ntre$ include befriending, counselling, complementary therapies and exercise classes. (b) The Southampton and Portsmouth minibus funding supports the operation of a patient transp)rt service. As part of our thr￿-year strategy, we set out an outreach programme to expand the numter of communities and areas supported by the charlty. (d) Transfers: In 2024 £1,894 was transferred to restricted funds to cover a shortfall. In 2023, £140,124 of the £153,588 relates to reclassifying Centres, income that had been incorrectly shown as restricted income in 2022, plus transfers after the completion of a Lymphoedema clinic in 2022. (c) Wessex Cancer Support Registered C¢Ji)p8ny No. 05416311 Page. 40 of 42 Wessex Cancer Support {Registered Company No: 05416311) Notes forming part of the financial statements for the year ended 31 De￿rnber 2024 22. Statement of funds Balance 1-1-24 Movement In resources Incomlng Outgolng Investment Movements Transfers Balance 31-11-24 Total restrlcted funds Unrestrlcted funds Deslgnated UnrestrlLted funds 300,902 199 312 162,667 1,200,000 1,505.947 2,705,947 (341,946) 858,054 1,390,812 2 248 866 1,335,150 1,335,150 1969 127 1,969,127 178,790 1,894 3,006,849 1,394.333 (2,168,439) 178,790 2,411,533 Balance 1-1-23 Movement In resources Incomlng Outgolng Investment Movements Transfers Balance 31-12-23 Total restrlcted funds Unrestrl(*ed funds Deslgnated Unr•strlded funds 652,091 126 938 324 539 153 588 300,902 1,200,000 1,191,706 2,391,706 {137,836) 1 549 862 1687 698 137,836 1,200,000 1,505,947 2,705,947 1,785,521 1,785,521 62,830 153 588 3,043,797 ￿1912 459 2,012 237 62,830 3,006,849 Designated funds have been set aside by the charity out of the unrestricted legacies received, to enable the charity to develop, improve and expand its reach and range of services as part of the strategic plan. 23. Analysis of net assets of the Group's funds Net Current Assets I (Llabllltles) Tanglble Flxed Assets Total 31-12-24 2024 Investments Restrlcted funds Unrestrlcted funds Deslgnated Funds Unrestrlcted funds 119 917 162 667 856,383 1142 400 1998 783 856,383 1392 483 2 248 866 215 963 215 963 1998 783 335 880 2 411533 Net Current Assets / (Liabllltles) Tanglble Flxed Assets Total 31-12-23 2023 Investments Restrlcted funds Unrestrlcted funds Deslgnated Funds Unrestrlcted funds 300 902 1,200,000 261758 1461758 1,200,000 1505 947 2 705 947 1223 776 1223 776 1461758 1467 540 3 006 849 Wessex Cancer Suppnrt Registered Conipany No. 05416311 41,:42 Wessex Cancer Support (Registered Company No: 05416311) Notes formin9 part of the financial ststements for the year ended 31 December 2024 24. Related party transactions The Trustees donated £1,050 to the charity in the year (2023: £nil). 25. Taxation As a charity, Wessex Cancer Support is exempt from Corporation Tax on profits applied to charitable purposes, under Settion 505 of the Income and Corporation Taxes Act 1988. The trading company uses the gift aid scheme to transfer an element of its profits to the charity. In 2024 the trading company distributed its taxable profits to the charity of £130,750 (2023: £101,895) under the gift aid scheme. In the current year the subsidiary has a deferred tsx liability of £6,756 (2023: £3,741). Of this, £3,300 relates to 2023 and £441 to tsx on 2022 profits. 26. Reconciliation of net movement in funds to net cash flow from operating activities Group 2024 2023 Net movement In funds Add back deprKlatlon charge uct Investment income racognlsed In the statsment of flnanclal actlvltl•s Add back unreallsed lo5sllgaln) on Investsnents Decreasel (Incrus•) In debtors Increasel (Decrease) In credltors Net cash Inflow from operatlng actlvltles (595,316) 30,592 (36,948) 30,824 (24,545) (178,790) 211,580 (40,426) (62,830) 360,195 19,963 270 778 562 897 27. Post balance sheet events There have been no post balan￿ sheet events. We¢sex Cancel. Support Registered Coii)pany No. 05416311 42,,142